Impact of HER2-low status on axillary response and surgical management after neoadjuvant chemotherapy in early breast cancer

被引：0
|
作者：
da Silva, Leonardo Roberto
Sartori, Guilherme
Ramalho, Susana
Reinert, Tomas
Da Rosa, Mahira Lopes
Tavares, Grazielle Morais
Mantovani, Higor
Vasconcelos, Vivian
Cabello, Ana Elisa Ribeiro Da Silva
Coelho, Guilherme
Mandelli, Jovana
Zaffaroni, Facundo
Barrios, Carlos
Graudenz, Marcia Silveira
Cabello, Cesar
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO5-17-12
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO5-17-12
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Favorable effect of HER2-low expression on prognosis for breast cancers after neoadjuvant chemotherapy
    Zhao, Yingying
    Yin, Wenjin
    Chen, Xinru
    Lu, Jingsong
    CANCER RESEARCH, 2024, 84 (09)
  • [32] Impact of Imaging After Neoadjuvant Chemotherapy on Surgical Management of Breast Cancer
    Breese, Rebecca
    Pu, Tracey
    Arif, Fatima
    Bennett, Stephanie
    Reed, Jennifer
    Friend, Kara
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 2) : S429 - S430
  • [33] Analyzing Neoadjuvant Chemotherapy Effects in HER2-Low Breast Cancer: Real World Data
    Antonini, Marcelo
    Mattar, Andre
    Richter, Fernanda G.
    Ramos, Marcellus N.
    Teixeira, Marina D.
    Pantarotto, Nathalia N.
    Matta, Nadia F.
    Amorim, Andressa G.
    Pinheiro, Denise J.
    Lopes, Reginaldo C.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (05)
  • [34] HER2-low status in inflammatory breast cancer (IBC) is associated with hormone receptors positivity but not with pathological response to neoadjuvant chemotherapy or overall survival
    de Nonneville, Alexandre
    Finetti, Pascal
    Boudin, Laurys
    Usclade, Lucas
    Viens, Patrice
    Viret, Frederic
    Mamessier, Emilie
    Goncalves, Anthony
    Bertucci, Francois
    CANCER RESEARCH, 2024, 84 (09)
  • [35] Axillary management after neoadjuvant chemotherapy in initially node positive early breast cancer
    Morales Murillo, Serafin
    Gasol Cudos, Ariadna
    Pallise Subirats, Ona
    Mele Olive, Jordi
    Canosa Morales, Carles
    Vilardell Villellas, Felip
    Sanchez Guzman, Douglas Rene
    Veas Rodriguez, Joel
    Rodriguez Galindo, Alvaro
    CANCER RESEARCH, 2021, 81 (04)
  • [36] Breast and axillary downstaging after neoadjuvant chemotherapy in breast cancer: surgical technique
    D'Alonzo, M.
    Minella, C.
    Villasco, A.
    Accomasso, F.
    Biglia, N.
    BREAST, 2021, 56 : S51 - S51
  • [37] Survival outcomes in HER2-low versus HER2-zero breast cancer after neoadjuvant chemotherapy: a meta-analysis
    Xia, Lin-Yu
    Cao, Xu-Chen
    Yu, Yue
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2024, 22 (01)
  • [38] Prognostic impact of axillary lymph node status after neoadjuvant chemotherapy for patients with breast cancer
    Nakamura, R.
    Yamamoto, N.
    Miyaki, T.
    Itami, M.
    CANCER RESEARCH, 2019, 79 (04)
  • [39] Prognostic Value of the Evolution of HER2-Low Expression after Neoadjuvant Chemotherapy
    Ma, Youzhao
    Zhu, Mingda
    Zhang, Jingyang
    Lv, Minhao
    Chen, Xiuchun
    Liu, Zhenzhen
    CANCER RESEARCH AND TREATMENT, 2023, 55 (04): : 1210 - 1221
  • [40] Clinicopathological characteristics and value of HER2-low expression evolution in breast cancer receiving neoadjuvant chemotherapy
    Shao, Yingbo
    Guan, Huijuan
    Luo, Zhifen
    Yu, Yang
    He, Yaning
    Chen, Qi
    Liu, Chaojun
    Zhu, Fangyuan
    Liu, Hui
    BREAST, 2024, 73
12345